![Suicide Risk From Weight-Loss Drugs Prompts More Questions](/i/c/7434225d-8019-49e0-e60e-48edc6576aaf.webp)
Suicide Risk From Weight-Loss Drugs Prompts More Questions
The European Union’s drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co.
2023-12-02 06:19
![Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies](/i/c/417897fc-cee0-756e-579e-a478cd39e257.webp)
Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies
By Patrick Wingrove (Reuters) -Novo Nordisk said on Thursday it sued one compounding pharmacy and refiled a lawsuit against another
2023-12-01 15:48
![Novo Nordisk shares rise as Wegovy shows heart benefits beyond weight loss](/i/c/51caa4ad-98d6-7488-7bc6-ef54a9fd6edf.webp)
Novo Nordisk shares rise as Wegovy shows heart benefits beyond weight loss
By Maggie Fick LONDON (Reuters) -Novo Nordisk shares rose 3% on Monday as the market reacted to data the drugmaker
2023-11-13 19:56
![Wegovy's heart benefits due to more than weight loss, Novo says](/i/c/4540bb56-4ab7-a744-07ac-8173f5974c39.webp)
Wegovy's heart benefits due to more than weight loss, Novo says
By Patrick Wingrove PHILADELPHIA (Reuters) -Novo Nordisk on Saturday said the heart protective benefits of its wildly popular Wegovy obesity
2023-11-12 22:48
![Novo to Build $6 Billion Plant as Obesity Drug Demand Surges](/i/c/0ab5a5e3-f5c1-1286-e9e4-6e08689617c6.webp)
Novo to Build $6 Billion Plant as Obesity Drug Demand Surges
Novo Nordisk A/S will invest more than 42 billion kroner ($6 billion) to expand its manufacturing facilities as
2023-11-10 21:22
![Weight-loss drug maker Novo Nordisk invests $6 billion to boost output](/i/c/25d00ef7-134e-f328-edb4-19841d7a4248.webp)
Weight-loss drug maker Novo Nordisk invests $6 billion to boost output
COPENHAGEN Novo Nordisk said on Friday it will invest more than 42 billion crowns ($6 billion) in its
2023-11-10 17:23
![Astra Enters Obesity Drug Race, Trumpets Price Potential](/i/c/abc22a8e-b091-081c-a70a-374aa7d16daa.webp)
Astra Enters Obesity Drug Race, Trumpets Price Potential
AstraZeneca Plc clinched a deal to develop a drug from the pharma industry’s hottest class of medicines and
2023-11-09 21:47
![European Stocks On Track for Best Run Since July on Fed Optimism](/i/c/ffcaf1ed-1d34-f319-4087-2f650fa63472.webp)
European Stocks On Track for Best Run Since July on Fed Optimism
European shares advanced for a fourth day, set for their longest winning streak since July, fueled by hopes
2023-11-02 18:48
![Novo Nordisk flags continued restrictions on Wegovy supplies](/i/c/c7208d86-673d-ca84-0e9a-bc59e04327c7.webp)
Novo Nordisk flags continued restrictions on Wegovy supplies
COPENHAGEN (Reuters) -Novo Nordisk on Thursday reported record sales and operating profits for the third quarter but flagged continued restrictions
2023-11-02 14:48
![When Japan Ends Negative Rate Policy, Treasuries Will Suffer](/i/c/2b64e3eb-e334-0898-8586-95aca206545f.webp)
When Japan Ends Negative Rate Policy, Treasuries Will Suffer
Japan’s era of negative interest rates will end in coming months, and the implications for world markets will
2023-10-23 08:56
![Novo Nordisk's Wegovy bonanza looms large in Denmark](/i/c/5af30eec-dbd3-4980-3fc6-96fe2d2fd46f.webp)
Novo Nordisk's Wegovy bonanza looms large in Denmark
By Maggie Fick COPENHAGEN The whirlwind success of weight-loss treatment Wegovy is providing a bonanza not just for
2023-10-05 14:52
![U.S. FDA found lapses at Novo's main U.S. factory in May 2022 -report](/i/c/b632aa9b-277c-91b7-8586-19daba1e291e.webp)
U.S. FDA found lapses at Novo's main U.S. factory in May 2022 -report
By Maggie Fick LONDON (Reuters) -U.S. drug regulators issued a report detailing quality control lapses at Novo Nordisk's main factory
2023-09-21 16:51